Research Article
SOX1 and PAX1 Are Hypermethylated in Cervical Adenocarcinoma and Associated with Better Prognosis
Figure 3
Algorithm combining clinicopathologic factor and genetic test results. The algorithm divided patients into high-risk and low-risk groups. The low-risk group showed a better 5-year overall survival (OS) rate (95.89% vs. 81.47%, ) (a) and better 5-year progression-free survival (PFS) rate (90.58% vs. 72.50%, ) than the high-risk group (b).
(a) |
(b) |